Evidence map›Paper›PMID 27930290›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS.

Melanie Lalancette-Hebert, Aarti Sharma, Alexander K Lyashchenko, Neil A Shneider

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic Variants inInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melanie Lalancette-HebertCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032.
Aarti SharmaCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032.
Alexander K LyashchenkoCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032.
Neil A ShneiderCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032; ns327@columbia.edu.

Funding

ADVANCED GRADUATE TRAINING PROGRAM IN NEUROBIOLOGY & BEHAVIORT32NS064928 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENGST, ULRICH · 2010 to 2024
$3.0M
Molecular profiling of gamma motor neuron developmentR21NS072573 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHNEIDER, NEIL ALAN · 2010 to 2011
$439k
NINDS NIH HHS R21 NS072573NINDS NIH HHS T32 NS064928
6 · The paper itself

Abstract

The molecular and cellular basis of selective motor neuron (MN) vulnerability in amyotrophic lateral sclerosis (ALS) is not known. In genetically distinct mouse models of familial ALS expressing mutant superoxide dismutase-1 (SOD1), TAR DNA-binding protein 43 (TDP-43), and fused in sarcoma (FUS), we demonstrate selective degeneration of alpha MNs (α-MNs) and complete sparing of gamma MNs (γ-MNs), which selectively innervate muscle spindles. Resistant γ-MNs are distinct from vulnerable α-MNs in that they lack synaptic contacts from primary afferent (I

Indexed as

Amyotrophic Lateral SclerosisAnimalsDisease Models, AnimalDNA-Binding ProteinsFemaleGenotypeMaleMiceMice, TransgenicMotor NeuronsMotor Neurons, GammaMusclesMutationNeurons, AfferentProprioceptionSpinal CordDNA-Binding ProteinsSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1ALSfusimotorgamma motor neuronmotor neuron disease

Identifiers

PMID27930290
PMCPMC5187676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.